insights_auto
Why is BEAM down 5,69%?
Dive Deeperchevron_right
BEAM:BMV
Beam Therapeutics Inc
MX$439,00
arrow_downward
-5,69%(-26,51) 1D
2 ຕ.ລ., 11 ໂມງ 11 ນາທີ 58 ວິນາທີ GMT-6 · MXN
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BEAM...
Mkt. cap
2,56 ຕື້
Avg. vol.
14,00
Volume
4,00
52-wk high
MX$663,44
52-wk low
MX$384,79
No. of employees
540
Mkt. cap
2,56 ຕື້
Avg. vol.
14,00
Volume
4,00
52-wk high
MX$663,44
52-wk low
MX$384,79
No. of employees
540
News stories
From web sources and news partners
GlobeNewswire
·
15 ນາທີກ່ອນ
ONAR Advances Nasdaq Listing Preparation Following Advertise Purple Acquisition and Financing
Simply Wall Street
·
20 ນາທີກ່ອນ
Applied Materials (AMAT) Deepens AI Chipmaking R And D With Major Foundry Partner
Yahoo Finance
·
15 ນາທີກ່ອນ
UMeWorld Upgrades to OTCQB Venture Market; Engages ARC Group Securities for Proposed Nasdaq Uplisting
Bloomberg.com
·
2 ຊົ່ວໂມງກ່ອນ
AI Bubble Risks Worst S&P 500 Crash Since 2008, Strategist Says
Profile
Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts. In the development of therapies, the company relies on CRISPR base editing and prime editing, whereby single nucleotides in a DNA sequence can be enzymatically modified without producing double-strand breaks. Wikipedia
About Beam Therapeutics Inc